End-Stage Renal Disease qualifies you for Medicare at any age. Here is when coverage starts and which plan choices you have.
Who qualifies for Medicare with ESRD?
Medicare is available at any age to people with End-Stage Renal Disease, permanent kidney failure requiring regular dialysis or a kidney transplant. To qualify, you must need ongoing dialysis or a transplant, and you or a spouse or parent must have enough work credits under Social Security or Railroad Retirement, or you must already receive those benefits. ESRD is one of only two conditions (the other is ALS) that grant Medicare before age 65 without the usual 24-month disability waiting period. This makes Medicare a lifeline for kidney patients of all ages. Call 1-800-MEDIGAP to confirm your eligibility and timing.
When does ESRD Medicare coverage begin?
Timing depends on your treatment. For in-center dialysis, Medicare generally starts on the first day of the fourth month of treatment. However, coverage can begin the first month if you participate in a home-dialysis training program, or even earlier if you receive a kidney transplant (coverage can start the month you are admitted for the transplant or related care). These start-date rules are nuanced and affect your out-of-pocket costs significantly. Acting quickly on home-dialysis training can move your coverage forward by months. 1-800-MEDIGAP can help you understand exactly when your coverage will start.
Plan options for ESRD patients
Since January 2021, people with ESRD can enroll in Medicare Advantage plans, a major change from prior rules that largely excluded them. You can also choose Original Medicare with a Part D drug plan, and in many states an ESRD diagnosis under 65 affects Medigap availability and pricing, since federal law does not guarantee Medigap access to those under 65. Some states require carriers to offer it anyway. Because immunosuppressant drugs after a transplant carry their own coverage rules, plan choice matters greatly for kidney patients. Call 1-800-MEDIGAP for free, situation-specific guidance.